- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Sep 27, 2021 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Sep 28, 2021 | T-952-20 | CMC | Google Llc V. Sonos, Inc. (Patent) | Ottawa | 1 h |
| Sep 28, 2021 | T-703-20 | CMC | Kaira District Coop Milk Producers Union Ltd Et Al V Amul Canada Ltd Et Al (Trade Mark) | Toronto | 30 m |
| Sep 28, 2021 | T-126-19 | TMC | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 1.5 h |
| Sep 28, 2021 | T-1769-19 | TMC | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 1.5 h |
| Sep 29, 2021 | T-1591-15 | CMC | Energizer Brands, Llc Et Al. V. The Gillette Company Et Al (Trade Mark) | Toronto | 30 m |
| Sep 29, 2021 | T-451-20 | M | Kobold Corporation Et Al. V. Ncs Multistage Inc. (Patent) | Calgary | 1 d |
| Sep 29, 2021 | T-710-21 | M | Aeritas, Llc V. Finnair Oyj (Patent) | Ottawa | 2 h |
| Sep 29, 2021 | T-1441-20 | M | Janssen Inc. Et Al V. Pharmascience Inc. (Patent - Paliperidone*) | Toronto | 3 h |
| Oct 1, 2021 | T-1268-20 | M | Janssen Inc. Et Al. V. Sandoz Canada Inc (Patent - Canagliflozin*) | Toronto | 6.5 h |
| Oct 1, 2021 | T-754-20 | CMC | Cinematix, Llc Et Al. V. Einthusan Et Al. (Copyright) | Ottawa | 30 m |
| Oct 1, 2021 | T-834-20 | M | Immigration Consultants Of Canada Regulatory Council V. Cicc Et Al. (Trade Mark) | Toronto | 1.5 h |
| Oct 1, 2021 | T-627-19 | CMC | Canadian Coalition For Firearms Rights Et Al V. Canada's National Firearms A (Trade Mark) | Calgary | 1 h |
| Oct 4, 2021 | T-33-21 | MED | Mcmaster Univsersity Et Al V. Bemo Academic Consulting Inc. (Trade Mark) | Toronto | 1 d |
| Oct 4, 2021 | T-646-15 | SENT | Canadian Standards Association V. P.s. Knight Co. Ltd. Et Al (Copyright) | Ottawa | 1 d |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Nov 1, 2021 | T-315-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Pharmascience Inc. (Patent - Lurasidone*) | Toronto | 10 d |
| Nov 1, 2021 | T-1443-18 | August Image, Llc V. Airg Inc. (Copyright) | Vancouver | 2 d |
| Nov 15, 2021 | T-815-17 | Pharmascience Inc. V. Meda Ab Et Al (PMNOC - Section 8 - Zolpidem*) | Montréal | 8 d |
| Nov 16, 2021 | T-347-20 | Eisai Limited Et Al V. Taro Pharmaceuticals Inc. (Patent - Perampanel*) | Toronto | 7 d |
| Nov 24, 2021 | T-315-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Pharmascience Inc. (Patent - Lurasidone*) | Toronto | 2 d |
| Dec 2, 2021 | T-347-20 | Eisai Limited Et Al V. Taro Pharmaceuticals Inc. (Patent - Perampanel*) | Toronto | 2 d |
| Dec 6, 2021 | T-418-20 | Merck Sharp & Dohme Corp Et Al. V. Sandoz Canada Inc (Patent - Sitagliptin*) | Toronto | 10 d |
| Dec 6, 2021 | T-419-20 | Merck Sharp & Dohme Corp Et Al. V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Dec 6, 2021 | T-270-20 | Bayer Inc. Et Al V. Pharmascience Inc. (Patent) | Ottawa | 10 d |
| Jan 10, 2022 | T-1591-15 | Energizer Brands, Llc Et Al. V. The Gillette Company Et Al (Trade Mark) | Toronto | 10 d |
| Jan 10, 2022 | T-1420-18 | Ncs Multistage Inc. V. Kobold Corporation, Et Al (Patent) | Calgary | 25 d |
| Jan 10, 2022 | T-567-20 | Ncs Multistage Inc. V. Promac Industries Ltd. (Patent) | Calgary | 25 d |
| Jan 17, 2022 | T-1660-11 | Bernard Charles Sherman Et Al V. Pfizer Canada Inc., Et Al (Patent - Quinapril*) | Toronto | 10 d |
| Jan 17, 2022 | T-497-18 | John Durant, John Durant Photographer Llc V. Trend Hunter Inc. (Copyright) | Toronto | 2 d |
| Jan 24, 2022 | T-509-21 | Ojo Labs, Inc. Et Al V. Re/max Community Inc (Trade Mark) | Toronto | 5 d |
| Jan 24, 2022 | T-549-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Macitentan*) | Toronto | 7 d |
| Feb 7, 2022 | T-555-20 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Apixaban*) | Toronto | 5 d |
| Feb 14, 2022 | T-1935-13 | Bernard Charles Sherman Et Al V. Pharmascience Inc (Patent - Quinapril*) | Toronto | 10 d |
| Feb 14, 2022 | T-1066-17 | T-rex Property Ab V. Pattison Outdoor Advertising Limited Partnership Et Al (Patent) | Toronto | 15 d |
| Feb 14, 2022 | T-827-20 | Viiv Healthcare Company, Shionogi & Co., Ltd. Et Al. V. Sandoz Canada Inc. (Patent - Dolutegravir*) | Toronto | 10 d |
| Feb 14, 2022 | T-1420-18 | Ncs Multistage Inc. V. Kobold Corporation, Et Al (Patent) | Calgary | 2 d |
| Feb 14, 2022 | T-567-20 | Ncs Multistage Inc. V. Promac Industries Ltd. (Patent) | Calgary | 2 d |
| Feb 28, 2022 | T-560-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-561-20 | Merck Sharp & Dohme Corp. Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-563-20 | Merck Sharp & Dohme Corp. Et Al V Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-665-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 28, 2022 | T-666-20 | Merck Sharp & Dohme Corp Et Al V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 14, 2022 | T-1662-17 | Crocs Canada, Inc. And Crocs Inc. V. Double Diamond Distribution Ltd. (Trade Mark) | Ottawa | 6 d |
| Mar 21, 2022 | T-126-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 25 d |
| Mar 21, 2022 | T-1769-19 | Tekna Plasma Systems Inc. V. Ap&c Advanced Powders & Coatings Inc. (Patent) | Montréal | 25 d |
| Mar 28, 2022 | T-667-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Mar 28, 2022 | T-798-20 | Opiant Pharmaceuticals Inc. Et Al V. Teva Canada Ltd. (Patent - Naloxone*) | Toronto | 10 d |
| Mar 28, 2022 | T-1187-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 10 d |
| Apr 4, 2022 | T-769-20 | Janssen Inc. Et Al. V. Jamp Pharma Corporation (Patent - Macitentan*) | Toronto | 10 d |
| Apr 25, 2022 | T-671-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Lurasidone*) | Toronto | 10 d |
| May 30, 2022 | T-2009-19 | Samsung Bioepis Co.,ltd. V. Fresenius Kabi Deutschlandf Gmbh (Patent - Adalimumab*) | Toronto | 10 d |
| Jun 6, 2022 | T-13-20 | Andritz Ltd Et Al. V. Cortex North America Corporation (Patent) | Montréal | 12 d |
| Jun 6, 2022 | T-891-20 | Sunovion Pharmaceuticals Canada Inc. Et Al V. Jamp Pharma Corporation (Patent - Lurasidone*) | Toronto | 10 d |
| Jun 13, 2022 | T-952-20 | Google Llc V. Sonos, Inc. (Patent) | Toronto | 10 d |
| Jul 4, 2022 | T-5-21 | Merck Sharp & Dohme Corp. Et Al V. Sandoz Canada Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Jul 4, 2022 | T-601-20 | Merck Sharp & Dohme Corp Et Al. V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Jul 4, 2022 | T-602-20 | Merck Sharp & Dohme Corp. Et Al. V. Apotex Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Jul 4, 2022 | T-668-20 | Merck Sharp & Dohme Corp. Et Al V. Jamp Pharma Corporation (Patent - Sitagliptin*) | Toronto | 12 d |
| Jul 4, 2022 | T-670-20 | Merck Sharp & Dohme Corp, Et Al V. Sandoz Canada Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Jul 4, 2022 | T-673-20 | Merck Sharp & Dohme Corp. Et Al V. Pharmascience Inc. (Patent - Sitagliptin*) | Toronto | 12 d |
| Jul 4, 2022 | T-414-21 | Merck Sharp & Dohme Corp. Et Al V. Sandoz Canada Inc. (Patent) | Toronto | 12 d |
| Jul 4, 2022 | T-1441-20 | Janssen Inc. Et Al V. Pharmascience Inc. (Patent - Paliperidone*) | Toronto | 10 d |
| Jul 5, 2022 | T-1207-20 | Pfizer Canada Ulc Et Al. V. Jamp Pharma Corporation (Patent - Tofacitinib*) | Toronto | 9 d |
| Aug 2, 2022 | T-1268-20 | Janssen Inc. Et Al. V. Sandoz Canada Inc (Patent - Canagliflozin*) | Toronto | 10 d |
| Aug 8, 2022 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Toronto | 20 d |
| Aug 15, 2022 | T-604-19 | Arysta Lifescience North America Et Al V. Agracity Crop Et Al (Patent) | Calgary | 15 d |
| Sep 6, 2022 | T-190-21 | Merck Sharp & Dohme Corp.et Al V. Teva Canada Limited (Patent - Sitagliptin*) | Toronto | 12 d |
| Sep 6, 2022 | T-253-21 | Merck Sharp & Dohme Corp. Et Al V. Teva Canada Limited (Patent - Sitagliptin*) | Toronto | 12 d |
| Sep 6, 2022 | T-251-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 12 d |
| Sep 6, 2022 | T-252-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 12 d |
| Sep 12, 2022 | T-16-21 | Boehringer Ingelheim (canada)ltd. Et Al V. Sandoz Canada Inc. (Patent - Linagliptin*) | Toronto | 15 d |
| Sep 26, 2022 | T-124-21 | Janssen Inc. Et Al V. Apotex Inc. (Patent - Paliperidone*) | Toronto | 10 d |
| Sep 29, 2022 | T-190-21 | Merck Sharp & Dohme Corp.et Al V. Teva Canada Limited (Patent - Sitagliptin*) | Toronto | 2 d |
| Sep 29, 2022 | T-251-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 2 d |
| Sep 29, 2022 | T-252-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 2 d |
| Sep 29, 2022 | T-253-21 | Merck Sharp & Dohme Corp. Et Al V. Teva Canada Limited (Patent - Sitagliptin*) | Toronto | 2 d |
| Oct 17, 2022 | T-415-21 | Merck Sharp & Dohme Corp. Et Al V. Sandoz Canada Inc. (Copyright - Sitagliptin*) | Toronto | 7 d |
| Oct 17, 2022 | T-6-21 | Merck Sharp & Dohme Corp. Et Al V. Sandoz Canada Inc. (Patent - Sitagliptin*) | Toronto | 7 d |
| Oct 17, 2022 | T-592-21 | Astrazeneca Canada Inc. Et Al V. Teva Canada Limited (Patent - Dapagliflozin*) | Toronto | 10 d |
| Oct 31, 2022 | T-383-21 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Dapagliflozin*) | Toronto | 9 d |
| Nov 14, 2022 | T-557-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Ottawa | 20 d |
| Nov 14, 2022 | T-559-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - ADALIMUMAB*) | Ottawa | 20 d |
| Nov 14, 2022 | T-560-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Ottawa | 20 d |
| Nov 14, 2022 | T-561-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - ADALIMUMAB*) | Ottawa | 20 d |
| Nov 14, 2022 | T-1531-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 15 d |
| Nov 14, 2022 | T-1533-20 | Boehringer Ingelheim (canada) Ltd Et Al V. Teva Canada Limited (Patent - Linagliptin*) | Toronto | 15 d |
| Nov 14, 2022 | T-572-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - ADALIMUMAB*) | Ottawa | 20 d |
| Nov 14, 2022 | T-573-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Ottawa | 20 d |
| Nov 14, 2022 | T-577-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - ADALIMUMAB*) | Ottawa | 20 d |
| Nov 14, 2022 | T-581-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Ottawa | 20 d |
| Nov 14, 2022 | T-380-21 | Biomarin Pharmaceutical Inc. V. Dr. Reddy's Laboratories Ltd. (Patent - Sapropterin*) | Toronto | 10 d |
| Dec 5, 2022 | T-373-21 | Bristol-myers Squibb Canada Co Et Al V. Sun Pharma Canada Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Dec 5, 2022 | T-1213-21 | Lundbeck Canada Inc. And H.lundbeck V. Apotex Inc. Et Al (Patent) | Toronto | 10 d |
| Dec 5, 2022 | T-668-21 | Lundbeck Canada Inc. Et Al. V. Apotex Inc. Et Al. (Patent) | Toronto | 10 d |
| Dec 13, 2022 | T-592-21 | Astrazeneca Canada Inc. Et Al V. Teva Canada Limited (Patent - Dapagliflozin*) | Toronto | 1 d |
| Dec 15, 2022 | T-383-21 | Astrazeneca Canada Inc. Et Al V. Sandoz Canada Inc. (Patent - Dapagliflozin*) | Toronto | 1 d |
| Dec 19, 2022 | T-557-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-559-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - ADALIMUMAB*) | Toronto | 3 d |
| Dec 19, 2022 | T-560-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-561-21 | Abbvie Corporation, Et Al V. Jamp Pharma Corporation (Patent - ADALIMUMAB*) | Toronto | 3 d |
| Dec 19, 2022 | T-572-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - ADALIMUMAB*) | Toronto | 3 d |
| Dec 19, 2022 | T-573-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Dec 19, 2022 | T-577-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - ADALIMUMAB*) | Toronto | 3 d |
| Dec 19, 2022 | T-581-21 | Jamp Pharma Corporation V. Abbvie Corporation Et Al. (Patent - Adalimumab*) | Toronto | 3 d |
| Jan 9, 2023 | T-1007-20 | Medexus Pharmaceuticals Inc. Et Al. V. Accord Healthcare Inc. (Patent) | Ottawa | 14 d |
| Jan 16, 2023 | T-249-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jan 16, 2023 | T-250-21 | Merck Sharp & Dohme Corp. Et Al V. Dr. Reddy's Laboratories Ltd. (Patent - Sitagliptin*) | Toronto | 10 d |
| Jan 16, 2023 | T-254-21 | Merck Sharp & Dohme Corp. Et Al V. Teva Canada Limited (Patent - Sitagliptin*) | Toronto | 10 d |
| Jan 16, 2023 | T-188-21 | Merck Sharp & Dohme Corp. Et Al V. Teva Canada Limited (Patent - Sitagliptin*) | Toronto | 10 d |
| Feb 27, 2023 | T-788-21 | Boehringer Ingelheim (canada) Ltd. Et Al V. Jamp Pharma Corporation (Patent) | Toronto | 15 d |
| Mar 20, 2023 | T-987-21 | Merck Sharp & Dohme Corp. Et Al. V. Accord Healthcare Inc. (Patent) | Toronto | 8 d |
| Jun 19, 2023 | T-607-21 | Apotex Inc. V. Janssen Inc. Et Al. (Patent) | Toronto | 10 d |
| Oct 10, 2023 | T-963-21 | Sandoz Canada Inc. V. Allergan Inc. (Patent) | Toronto | 9 d |
| Oct 31, 2023 | T-963-21 | Sandoz Canada Inc. V. Allergan Inc. (Patent) | Toronto | 1 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Oct 12, 2021 | T-530-21 | Beijing Judian Restaurant Co. Ltd. V. Wei Meng | Trade Mark Opposition | Vancouver | 1 d |
| Nov 1, 2021 | T-1935-19 | Align Technology, Inc. V. Osstemimplant Co., Ltd. | Trade Mark - Appeal of a decision of the Registrar | Toronto | 3 h |
| Nov 3, 2021 | T-1166-21 | Canadian Standards Association V. P.s. Knight Co. Ltd. Et Al | Copyright Infringement [Applications] | Ottawa | 3 h |
| Dec 13, 2021 | T-1047-21 | Catalyst Pharmaceuticals, Inc. Et Al. V. Attorney General Of Canada Et Al. | S. 18.1 Application for Judicial Review | Toronto | 3 d |
| Dec 15, 2021 | T-258-21 | Viiv Healthcare Ulc V. The Minister Of Health - DOLUTEGRAVIR* | S. 18.1 Application for Judicial Review | Toronto | 1 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Oct 7, 2021 | A-165-21 | Bernard Charles Sherman Et Al. V. Pfizer Canada Inc. Et Al | Appeal (S.27 - Interloc.) - Patent Act | Toronto | 3 h |
| Oct 19, 2021 | A-143-21 | Merck Canada Inc. V. Minister Of Health - Pembrolizumab* | Appeal (S.27 - Final) - Application for Judicial Review [from T-1476-20 - S. 18.1 Application for Judicial Review] | Ottawa | 3 h |
| Oct 20, 2021 | A-179-20 | Canada Rna Biochemical Inc V. Canada (minister Of Health) Et Al | Appeal (S.27 - Final) - Application for Judicial Review [from T-1304-16 - S. 18.1 Application for Judicial Review] | Ottawa | 4 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.